Multiple sclerosis disease-modifying therapy use in the Department of Veteran Affairs and Medicare: A comparative analysis

Abstract: Background: High-cost disease-modifying therapies (DMT) for multiple sclerosis (MS) have created affordability challenges for people with MS (PwMS) and payers. The …